Vaxcyte gets FDA fast track designation for PCV candidate VAX-24

Vaxcyte has secured fast track designation for VAX-24, its 24-valent pneumococcal conjugate vaccine (PCV) candidate, from the US Food and Drug Administration (FDA) for the ... Read More